[go: up one dir, main page]

TW200704410A - Controlled release medicinal composition of sleeping drug and method for producing the same - Google Patents

Controlled release medicinal composition of sleeping drug and method for producing the same

Info

Publication number
TW200704410A
TW200704410A TW094131869A TW94131869A TW200704410A TW 200704410 A TW200704410 A TW 200704410A TW 094131869 A TW094131869 A TW 094131869A TW 94131869 A TW94131869 A TW 94131869A TW 200704410 A TW200704410 A TW 200704410A
Authority
TW
Taiwan
Prior art keywords
drug
sleeping
medicinal composition
controlled release
producing
Prior art date
Application number
TW094131869A
Other languages
English (en)
Other versions
TWI302462B (zh
Inventor
Qin-Zhi Jiang
ting-wei Zhang
Original Assignee
Orient Europharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orient Europharma Co Ltd filed Critical Orient Europharma Co Ltd
Publication of TW200704410A publication Critical patent/TW200704410A/zh
Application granted granted Critical
Publication of TWI302462B publication Critical patent/TWI302462B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW094131869A 2005-07-20 2005-09-15 Controlled release medicinal composition of sleeping drug and method for producing the same TW200704410A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/186,348 US20070020333A1 (en) 2005-07-20 2005-07-20 Controlled release of hypnotic agents

Publications (2)

Publication Number Publication Date
TW200704410A true TW200704410A (en) 2007-02-01
TWI302462B TWI302462B (zh) 2008-11-01

Family

ID=37679341

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094131869A TW200704410A (en) 2005-07-20 2005-09-15 Controlled release medicinal composition of sleeping drug and method for producing the same

Country Status (8)

Country Link
US (1) US20070020333A1 (zh)
EP (1) EP1919445A4 (zh)
JP (2) JP2009501796A (zh)
KR (1) KR20080038133A (zh)
AU (1) AU2006279275A1 (zh)
CA (1) CA2615775A1 (zh)
TW (1) TW200704410A (zh)
WO (1) WO2007018710A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI426929B (zh) * 2008-03-17 2014-02-21 Orient Pharma Co Ltd 持續性釋放之含抗生素醫藥組合物、製備法及其應用

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI505841B (zh) * 2011-09-29 2015-11-01 Taiwan Biotech Co Ltd 治療睡眠障礙之控釋調配物
CA2934595C (en) * 2014-02-06 2022-06-21 Sequential Medicine Limited Composition and method for aiding sleep
WO2019071270A1 (en) * 2017-10-06 2019-04-11 Adare Pharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
ATE66143T1 (de) * 1985-01-11 1991-08-15 Abbott Lab Feste zubereitung mit langsamer freisetzung.
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
AU7966694A (en) * 1993-07-21 1996-05-02 University Of Kentucky Research Foundation, The A multicompartment hard capsule with control release properties
US5433951A (en) * 1993-10-13 1995-07-18 Bristol-Myers Squibb Company Sustained release formulation containing captopril and method
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (en) * 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20040258750A1 (en) * 1999-06-28 2004-12-23 Gerard Alaux Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
US6485746B1 (en) * 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
ATE241968T1 (de) * 1999-08-26 2003-06-15 Neurocrine Biosciences Inc Sedativ hypnotische zusammensetzungen mit gesteuerter freisetzung und diesbezügliche verfahren
WO2001078725A2 (en) * 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI426929B (zh) * 2008-03-17 2014-02-21 Orient Pharma Co Ltd 持續性釋放之含抗生素醫藥組合物、製備法及其應用

Also Published As

Publication number Publication date
JP2009501796A (ja) 2009-01-22
AU2006279275A1 (en) 2007-02-15
US20070020333A1 (en) 2007-01-25
KR20080038133A (ko) 2008-05-02
EP1919445A1 (en) 2008-05-14
TWI302462B (zh) 2008-11-01
WO2007018710A1 (en) 2007-02-15
CA2615775A1 (en) 2007-02-15
EP1919445A4 (en) 2010-07-14
JP4866170B2 (ja) 2012-02-01
JP2007023043A (ja) 2007-02-01

Similar Documents

Publication Publication Date Title
GEP20063905B (en) Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
IL183357A0 (en) Oral medicament for the modified release of at least one active principle, in multimicrocapsule form
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
IL195294A (en) A process for the manufacture of high purity spinamide or relapinamide, their use in the preparation of medicaments and medicinal preparations containing them
CA2963423A1 (en) Device and method for delivery of a medicament
IL183982A0 (en) Controlled release formulation for oral administration for treating diabetes containing metformin and methods for the preparation thereof
WO2009002867A3 (en) Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
IL189914A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method of producing them, their use as medicament, and also medicament containing them
TW200607799A (en) Therapeutic compounds: pyridine as scaffold
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
IL181445A0 (en) Use of (halobenzyloxy)benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium selective modulators
IL195931A0 (en) Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production
IL179758A0 (en) Substituted tetrahydro - 2h - isoquinolin - 1 - one derivatives, method for the production thereof, and use of the same as medicaments
WO2007144169A3 (en) Entacapone-derivatives
EP1783137A4 (en) GALACTOSIS DERIVATIVE, DRUG VECTOR AND THERAPEUTIC PREPARATION
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
ATE458748T1 (de) Proteinbindende methotrexat-derivate und diese enthaltende arzneimittel
IL184697A (en) Diclofenac Injection Composition, Process for its Preparation and Use for Medication and Pain Relief and / or Inflammation
TW200704410A (en) Controlled release medicinal composition of sleeping drug and method for producing the same
ZA200705080B (en) Aminocarboxylic acid derivative and medicinal use thereof
PL378106A1 (pl) Sposób wytwarzania zawierającej fibrat kompozycji farmaceutycznej w postaci tabletek oraz tabletki otrzymane tym sposobem
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
IL173918A0 (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same
WO2007111933A3 (en) Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees